FDA Approves First mRNA Flu Vaccine in Landmark Decision for Moderna
The US Food and Drug Administration has approved Moderna’s mRNA flu vaccine for commercial use, ending a years-long regulatory review and opening new applications for mRNA technology in infectious disease prevention.